PMPS Article (Samedan): February 2016

Download PDF

Go With the Flow – Testing Inhaled Generics

Increasing global requirements for efficacious, inexpensive products to treat respiratory illnesses are driving the development of inhaled generics. In vitro methods represent the most efficient way of proving bioequivalence – and can thereby aid a faster time to market.